| Literature DB >> 17003011 |
Assimina Galli-Tsinopoulou1, Sanda Nousia-Arvanitakis, Ioannis Tsinopoulos, Christos Bechlivanides, Orit Shevah, Zvi Laron.
Abstract
Laron-type dwarfism is an autosomal recessive disorder caused by deletions or mutations of the growth hormone receptor gene. It is characterized by high circulating levels of growth hormone (GH) and low levels of insulin-like growth factor I (IGF-I). Patients are refractory to both endogenous and exogenous GH, and present severe growth retardation and obesity. Therapy with recombinant human insulin-like growth factor-I (rhIGF-I) accelerates linear growth. We describe a 2-year old girl with Laron syndrome, who presented with postnatal growth failure and hypoglycaemic seizures. Her evaluation disclosed high GH values during a glucagon test (peak GH value 170 ng/ml) and very low IGF I value (0.1 ng/ml) with no rise following GH administration. The growth velocity improved considerably with the administration of IGF I. Molecular analysis showed a heterozygous mutation on exon 4 of the GH receptor gene, inherited from the mother, a rather puzzling finding considering the clinical findings in mother and infant. This case constitutes the first report of Laron syndrome from Greece.Entities:
Year: 2003 PMID: 17003011 DOI: 10.14310/horm.2002.1191
Source DB: PubMed Journal: Hormones (Athens) ISSN: 1109-3099 Impact factor: 2.885